Zheng‐Jun Zhou
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 2%
- Immune cells in cancer
Papers in
-
- Circular RNAs in diseases 7
- RNA modifications and cancer 7
- Ubiquitin and proteasome pathways 3
- Surgery 14
- Cholangiocarcinoma and Gallbladder Cancer Studies 13
- Co-authors
- Shao‐Lai Zhou (45 shared papers)Jia Fan (35 shared papers)Jian Zhou (23 shared papers)Zhiqiang Hu (26 shared papers)Zhi Dai (22 shared papers)Xiaowu Huang (15 shared papers)Ya Cao (6 shared papers)Zheng Wang (5 shared papers)
- Journals
- Hepatology (7 papers)Cancer Letters (3 papers)Journal of Neuropathology & Experimental Neurology (2 papers)Cancer Research (2 papers)Theranostics (2 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Zheng‐Jun Zhou
71 papers receiving 3.7k citations
Zheng‐Jun Zhou's Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 921
- Immunology 1.1k
- Oncology 1.1k
- Hepatology 301
- Molecular Biology 1.4k
Countries citing papers authored by Zheng‐Jun Zhou
This map shows the geographic impact of Zheng‐Jun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng‐Jun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng‐Jun Zhou more than expected).
Fields of papers citing papers by Zheng‐Jun Zhou
This network shows the impact of papers produced by Zheng‐Jun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng‐Jun Zhou. The network helps show where Zheng‐Jun Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Zheng‐Jun Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib Hit paper breakdown → | 2016 | 680 |
| 2 | 2012 | 301 | |
| 3 | 2014 | 197 | |
| 4 | 2019 | 184 | |
| 5 | 2016 | 171 | |
| 6 | 2019 | 169 | |
| 7 | 2014 | 158 | |
| 8 | 2013 | 140 | |
| 9 | 2012 | 112 | |
| 10 | 2009 | 106 | |
| 11 | 2022 | 104 | |
| 12 | 2021 | 102 | |
| 13 | 2019 | 100 | |
| 14 | 2014 | 89 | |
| 15 | 2022 | 82 | |
| 16 | 2015 | 66 | |
| 17 | 2017 | 64 | |
| 18 | 2019 | 56 | |
| 19 | 2019 | 53 | |
| 20 | 2014 | 47 |
About Zheng‐Jun Zhou
Zheng‐Jun Zhou is a scholar working on Molecular Biology, Surgery, Oncology, Immunology and Cancer Research, having authored 71 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Circular RNAs in diseases (7 papers), RNA modifications and cancer (7 papers), Immune cells in cancer (5 papers), Peptidase Inhibition and Analysis (4 papers), Ferroptosis and cancer prognosis (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (921 citations), Immunology (1.1k citations), Oncology (1.1k citations), Hepatology (301 citations) and Molecular Biology (1.4k citations). Zheng‐Jun Zhou has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Shao‐Lai Zhou, Jia Fan, Jian Zhou, Zhiqiang Hu, Zhi Dai, Xiaowu Huang, Ya Cao, Zheng Wang, Erbao Chen and Chu‐Bin Luo. Their work appears in journals such as Hepatology, Cancer Letters, Journal of Neuropathology & Experimental Neurology, Cancer Research and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.